Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Myron Levin

Concepts (855)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Herpes Zoster
106
2025
315
17.950
 Why?
Herpes Zoster Vaccine
66
2025
154
16.460
 Why?
Herpesvirus 3, Human
87
2025
333
12.140
 Why?
Antibodies, Viral
67
2026
666
5.040
 Why?
Chickenpox
24
2023
81
4.950
 Why?
Immunity, Cellular
36
2024
268
4.500
 Why?
Chickenpox Vaccine
27
2023
75
3.740
 Why?
Influenza Vaccines
18
2024
515
2.870
 Why?
Vaccines, Attenuated
32
2024
130
2.630
 Why?
HIV Infections
39
2026
3031
2.460
 Why?
Neuralgia, Postherpetic
18
2019
39
2.360
 Why?
Immunocompromised Host
13
2019
201
2.340
 Why?
Antiviral Agents
28
2022
741
2.220
 Why?
Adjuvants, Immunologic
17
2023
238
2.060
 Why?
Simplexvirus
24
2016
82
2.040
 Why?
Acyclovir
27
2016
96
1.980
 Why?
Herpes Simplex
17
2016
93
1.840
 Why?
Vaccination
33
2023
1406
1.790
 Why?
DNA, Viral
24
2018
361
1.680
 Why?
Trypanosoma cruzi
13
2007
40
1.640
 Why?
Papillomavirus Vaccines
13
2018
298
1.500
 Why?
Viral Envelope Proteins
6
2021
98
1.420
 Why?
Herpesvirus 1, Human
10
2016
80
1.420
 Why?
Influenza, Human
13
2024
608
1.370
 Why?
Pregnancy Complications, Infectious
16
2020
419
1.360
 Why?
Vaccines, Synthetic
16
2025
140
1.360
 Why?
Humans
296
2026
142694
1.320
 Why?
T-Lymphocytes
20
2019
2034
1.300
 Why?
Antiretroviral Therapy, Highly Active
13
2017
277
1.290
 Why?
Aged
92
2024
25298
1.250
 Why?
Immunologic Memory
12
2019
363
1.240
 Why?
Aged, 80 and over
47
2022
8009
1.240
 Why?
Immunization, Secondary
13
2017
90
1.220
 Why?
CD4-Positive T-Lymphocytes
13
2023
1126
1.180
 Why?
Antibodies, Protozoan
5
2007
41
1.120
 Why?
Papillomavirus Infections
9
2018
352
1.110
 Why?
Middle Aged
102
2026
35226
1.050
 Why?
Ribosomal Proteins
6
2006
93
1.030
 Why?
Double-Blind Method
33
2026
1999
1.010
 Why?
Chagas Disease
8
2007
44
1.000
 Why?
Pneumococcal Vaccines
4
2026
129
0.990
 Why?
Female
158
2026
76894
0.990
 Why?
Protozoan Proteins
6
2006
93
0.970
 Why?
Male
141
2026
71079
0.940
 Why?
T-Lymphocyte Subsets
6
2019
418
0.930
 Why?
Vaccines, Inactivated
9
2023
69
0.870
 Why?
Receptors, Adrenergic, beta-1
4
2007
22
0.860
 Why?
Viral Vaccines
12
2014
107
0.860
 Why?
Antibodies, Neutralizing
13
2023
329
0.860
 Why?
Incidence
22
2023
2828
0.840
 Why?
Herpesvirus 2, Human
6
2014
28
0.830
 Why?
Virus Latency
4
2014
80
0.800
 Why?
Interferon-gamma
18
2022
789
0.790
 Why?
Immune Sera
4
2020
76
0.780
 Why?
Respiratory Syncytial Virus, Human
3
2019
82
0.780
 Why?
CD8-Positive T-Lymphocytes
5
2018
928
0.760
 Why?
B-Lymphocytes
9
2021
885
0.760
 Why?
Enzyme-Linked Immunosorbent Assay
22
2021
850
0.750
 Why?
Injections, Intramuscular
5
2022
135
0.750
 Why?
Influenza A Virus, H1N1 Subtype
6
2017
153
0.720
 Why?
Age Factors
17
2021
3266
0.710
 Why?
Respiratory Syncytial Virus Vaccines
2
2019
39
0.710
 Why?
Rotavirus Infections
3
2017
35
0.700
 Why?
Drug Resistance, Viral
7
2009
119
0.700
 Why?
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
6
2017
13
0.690
 Why?
Influenza B virus
6
2012
45
0.660
 Why?
Anti-Retroviral Agents
5
2018
239
0.650
 Why?
Vaccination Coverage
2
2018
102
0.640
 Why?
Rotavirus Vaccines
2
2017
37
0.630
 Why?
Adenovirus Infections, Human
4
2015
16
0.620
 Why?
Infectious Disease Transmission, Vertical
7
2020
184
0.610
 Why?
Adult
77
2026
39755
0.600
 Why?
Down Syndrome
2
2023
523
0.600
 Why?
Th1 Cells
3
2018
137
0.590
 Why?
Clinical Trials as Topic
15
2019
1038
0.590
 Why?
Polymerase Chain Reaction
13
2019
1050
0.590
 Why?
Child, Preschool
43
2026
11599
0.580
 Why?
Insurance Claim Review
1
2019
83
0.570
 Why?
HIV
4
2010
247
0.570
 Why?
AIDS-Related Opportunistic Infections
4
2015
128
0.570
 Why?
Cytomegalovirus Infections
4
2015
200
0.560
 Why?
Alphapapillomavirus
4
2016
36
0.560
 Why?
Influenza A Virus, H3N2 Subtype
4
2017
49
0.560
 Why?
CD4 Lymphocyte Count
14
2017
274
0.560
 Why?
Antibody Formation
8
2023
293
0.550
 Why?
Child
60
2026
22376
0.540
 Why?
Immunoglobulin G
11
2021
892
0.540
 Why?
Dose-Response Relationship, Immunologic
3
2016
77
0.530
 Why?
Infant
31
2023
9849
0.530
 Why?
Virus Shedding
6
2017
48
0.530
 Why?
Health Expenditures
1
2019
189
0.520
 Why?
Pneumonia
1
2023
640
0.510
 Why?
Adolescent
54
2026
22136
0.510
 Why?
Pain
6
2022
771
0.510
 Why?
Anti-HIV Agents
6
2015
861
0.510
 Why?
Cytosine
3
2015
46
0.500
 Why?
Herpesviridae Infections
4
2015
149
0.500
 Why?
Interleukin-2
7
2022
445
0.500
 Why?
Infant, Premature
5
2020
606
0.490
 Why?
Antigens, Viral
21
2017
179
0.480
 Why?
Organophosphonates
2
2015
96
0.480
 Why?
Cytomegalovirus
7
2006
167
0.470
 Why?
Injections, Subcutaneous
1
2016
164
0.470
 Why?
Guanine
14
2006
80
0.460
 Why?
Enzyme-Linked Immunospot Assay
4
2018
37
0.460
 Why?
Follow-Up Studies
22
2019
5276
0.460
 Why?
Refrigeration
2
2018
12
0.450
 Why?
Immunization
5
2014
374
0.450
 Why?
Polyomavirus Infections
1
2015
30
0.440
 Why?
Health Care Costs
1
2018
414
0.440
 Why?
Immunity, Humoral
3
2021
117
0.430
 Why?
Viral Load
12
2018
513
0.430
 Why?
Uterine Cervical Neoplasms
5
2016
274
0.430
 Why?
Skin Diseases
1
2016
147
0.430
 Why?
Oropharynx
1
2014
47
0.420
 Why?
Herpes Genitalis
7
2014
18
0.420
 Why?
Blood
1
2014
112
0.420
 Why?
Drug Combinations
4
2023
371
0.410
 Why?
Infant, Newborn
28
2023
6315
0.400
 Why?
Immunogenicity, Vaccine
4
2022
35
0.400
 Why?
Vaccines
3
2018
386
0.390
 Why?
Monocytes
8
2025
542
0.390
 Why?
T-Lymphocytes, Regulatory
1
2016
390
0.390
 Why?
Herpes Labialis
3
2013
8
0.380
 Why?
Trigeminal Ganglion
2
2003
23
0.380
 Why?
Placebos
8
2017
192
0.380
 Why?
Time Factors
20
2021
7010
0.380
 Why?
Post-Exposure Prophylaxis
2
2023
13
0.360
 Why?
United States
18
2026
15499
0.360
 Why?
Aging
10
2017
1963
0.360
 Why?
Sensory Receptor Cells
1
2012
101
0.360
 Why?
Young Adult
24
2023
13817
0.350
 Why?
Retrospective Studies
16
2023
16647
0.350
 Why?
Randomized Controlled Trials as Topic
8
2021
1655
0.350
 Why?
RNA, Viral
21
2018
690
0.350
 Why?
Communicable Diseases
1
2014
162
0.350
 Why?
Quality of Life
7
2021
3068
0.320
 Why?
Human papillomavirus 18
5
2018
14
0.320
 Why?
Human papillomavirus 16
5
2018
31
0.310
 Why?
Glycoproteins
2
2023
356
0.310
 Why?
Databases, Factual
4
2019
1452
0.310
 Why?
Pregnancy
20
2020
7129
0.310
 Why?
Animals
42
2021
37909
0.310
 Why?
Induced Pluripotent Stem Cells
1
2012
273
0.310
 Why?
Chagas Cardiomyopathy
4
2007
27
0.300
 Why?
Cost-Benefit Analysis
4
2024
614
0.300
 Why?
Poverty
1
2013
521
0.300
 Why?
Frail Elderly
2
2020
129
0.290
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2009
19
0.290
 Why?
Vaccines, Subunit
5
2021
52
0.290
 Why?
Risk Factors
20
2023
10569
0.290
 Why?
Treatment Outcome
19
2016
11341
0.280
 Why?
Varicella Zoster Virus Infection
2
2018
24
0.270
 Why?
Epitopes
4
2005
486
0.270
 Why?
Activities of Daily Living
3
2021
429
0.270
 Why?
Meningitis, Viral
3
1997
20
0.270
 Why?
Meningitis
1
2008
80
0.260
 Why?
Hemagglutination Inhibition Tests
7
2017
38
0.260
 Why?
Seasons
3
2023
545
0.260
 Why?
Antibodies, Monoclonal
3
2023
1469
0.260
 Why?
Research Design
2
2013
1113
0.260
 Why?
Autoantibodies
3
2007
1494
0.260
 Why?
Viral Plaque Assay
8
2012
32
0.250
 Why?
Cytokines
7
2018
2086
0.250
 Why?
Cells, Cultured
19
2012
4150
0.250
 Why?
Recurrence
14
2019
1117
0.250
 Why?
Viremia
5
2018
158
0.250
 Why?
Prospective Studies
25
2019
7845
0.250
 Why?
Neurons
6
2003
1613
0.240
 Why?
Immunocompetence
4
2019
46
0.240
 Why?
Respiratory Syncytial Virus Infections
3
2017
136
0.230
 Why?
Nucleic Acid Hybridization
11
2006
188
0.230
 Why?
Neoplasms
3
2016
2798
0.230
 Why?
Drug-Related Side Effects and Adverse Reactions
4
2017
252
0.230
 Why?
Virus Replication
12
2018
536
0.220
 Why?
Sleep Wake Disorders
4
2013
311
0.220
 Why?
Intestines
2
2018
353
0.220
 Why?
Nucleosides
1
2004
25
0.220
 Why?
Cross Reactions
6
2014
133
0.220
 Why?
Cell Count
2
2005
322
0.220
 Why?
Severity of Illness Index
14
2015
2905
0.220
 Why?
Vaccine Potency
3
2019
6
0.220
 Why?
Transforming Growth Factor beta1
1
2025
175
0.220
 Why?
Viral Proteins
5
2018
363
0.210
 Why?
Molecular Sequence Data
9
2006
2891
0.210
 Why?
Influenza A virus
5
2012
112
0.210
 Why?
Health Resources
2
2019
128
0.210
 Why?
Nonlinear Dynamics
1
2005
94
0.210
 Why?
Phosphoproteins
1
2006
338
0.210
 Why?
Interferons
9
1982
191
0.210
 Why?
Herpesvirus 4, Human
3
2014
172
0.200
 Why?
Cholecalciferol
1
2024
60
0.200
 Why?
Genetic Variation
1
2008
984
0.200
 Why?
Neuralgia
4
2010
142
0.200
 Why?
Immunoassay
2
2017
112
0.200
 Why?
Long-Term Care
1
2024
113
0.200
 Why?
Antibody Affinity
2
2021
60
0.190
 Why?
Cricetinae
6
2007
296
0.190
 Why?
Enterovirus Infections
5
1995
174
0.190
 Why?
Transforming Growth Factor beta
1
2025
481
0.190
 Why?
Encephalitis
2
1995
139
0.190
 Why?
Ganglia, Spinal
2
1993
88
0.190
 Why?
Developing Countries
2
2016
312
0.190
 Why?
CHO Cells
3
2007
164
0.190
 Why?
Pain Measurement
8
2019
547
0.180
 Why?
Lymphocyte Activation
13
2015
1135
0.180
 Why?
Virus Activation
4
2010
86
0.180
 Why?
Antibodies, Bacterial
4
2026
145
0.180
 Why?
Recombinant Proteins
4
2018
1349
0.180
 Why?
Papillomaviridae
3
2011
120
0.180
 Why?
Lymphocytosis
1
2021
11
0.180
 Why?
Longitudinal Studies
8
2018
2930
0.170
 Why?
Immunosenescence
1
2021
5
0.170
 Why?
Mice
12
2021
18309
0.170
 Why?
Cell Separation
1
2002
310
0.170
 Why?
Herpes Simplex Virus Vaccines
2
2012
4
0.170
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2021
76
0.170
 Why?
Genes, Protozoan
1
2000
13
0.170
 Why?
Virology
1
2001
36
0.170
 Why?
Fluorescent Antibody Technique
6
2016
375
0.170
 Why?
Intermediate Filament Proteins
1
2000
57
0.160
 Why?
Case-Control Studies
5
2018
3601
0.160
 Why?
Fetal Diseases
4
1991
190
0.160
 Why?
Cell Line
16
2018
2884
0.160
 Why?
Amino Acid Sequence
5
2006
2125
0.160
 Why?
RNA Helicases
1
2000
32
0.160
 Why?
Fibroblasts
10
2018
1028
0.160
 Why?
Vitamin D
1
2024
398
0.160
 Why?
Immunoglobulin A
3
2017
217
0.160
 Why?
Terminal Repeat Sequences
1
2000
18
0.160
 Why?
Health Services for the Aged
1
2001
72
0.160
 Why?
Short Interspersed Nucleotide Elements
1
2000
11
0.160
 Why?
Feces
3
2017
499
0.160
 Why?
Enterovirus
3
1995
83
0.160
 Why?
HIV-1
5
2018
897
0.160
 Why?
Laboratories
1
2001
110
0.160
 Why?
Acquired Immunodeficiency Syndrome
2
1993
230
0.160
 Why?
Cohort Studies
10
2022
5820
0.160
 Why?
Antidepressive Agents
2
2013
238
0.160
 Why?
Carrier Proteins
2
2001
742
0.160
 Why?
Immunoenzyme Techniques
3
2006
200
0.150
 Why?
Retroelements
1
2000
52
0.150
 Why?
Epitope Mapping
3
2005
61
0.150
 Why?
Immunization, Passive
4
1994
87
0.150
 Why?
Antibodies, Monoclonal, Humanized
1
2026
932
0.150
 Why?
Dietary Supplements
1
2024
571
0.150
 Why?
Leukocytes, Mononuclear
5
2010
578
0.150
 Why?
Base Sequence
10
2007
2167
0.150
 Why?
Myocytes, Cardiac
1
2004
545
0.150
 Why?
Immunization Schedule
3
2016
187
0.150
 Why?
Pneumococcal Infections
2
2013
104
0.150
 Why?
Hemophilia A
2
1993
145
0.150
 Why?
Delivery of Health Care, Integrated
1
2022
297
0.150
 Why?
Myocardium
3
2001
938
0.140
 Why?
Heart Transplantation
2
2007
725
0.140
 Why?
Liver Transplantation
1
2006
779
0.140
 Why?
Cholera Toxin
1
2018
30
0.140
 Why?
Autophagosomes
1
2018
20
0.140
 Why?
Infant, Premature, Diseases
3
1995
107
0.140
 Why?
Microbial Sensitivity Tests
8
2005
370
0.140
 Why?
Age Distribution
3
2016
394
0.140
 Why?
Sex Distribution
3
2016
379
0.140
 Why?
Killer Cells, Natural
2
2025
472
0.140
 Why?
Fatty Acid-Binding Proteins
1
2018
73
0.140
 Why?
Viral Fusion Proteins
1
2017
18
0.140
 Why?
Lymphocytes
8
1998
390
0.140
 Why?
Drug Therapy, Combination
4
2016
1031
0.140
 Why?
Regression Analysis
2
2019
995
0.140
 Why?
Simian virus 40
11
1977
24
0.140
 Why?
Genes, Viral
2
2006
92
0.130
 Why?
Lysosomes
1
2018
132
0.130
 Why?
Immune Evasion
1
2018
66
0.130
 Why?
Multivariate Analysis
2
2018
1493
0.130
 Why?
Clinical Trials, Phase II as Topic
1
2017
77
0.130
 Why?
Protein Subunits
1
2018
227
0.130
 Why?
Clinical Trials, Phase I as Topic
1
2017
52
0.130
 Why?
Lysosomal-Associated Membrane Protein 1
1
2017
12
0.130
 Why?
Hepatitis B Vaccines
2
2026
42
0.130
 Why?
Disease Transmission, Infectious
1
2018
68
0.130
 Why?
Cell Division
5
2003
780
0.130
 Why?
Cryopreservation
1
2018
110
0.130
 Why?
Cost of Illness
5
2014
315
0.130
 Why?
Observational Studies as Topic
1
2017
126
0.130
 Why?
Body Mass Index
1
2026
2432
0.130
 Why?
Models, Biological
1
2005
1826
0.130
 Why?
Adverse Drug Reaction Reporting Systems
1
2017
80
0.130
 Why?
Infectious Mononucleosis
2
1991
10
0.130
 Why?
Receptors, Muscarinic
1
1996
19
0.130
 Why?
Receptors, Adrenergic, beta-2
1
1996
35
0.120
 Why?
Infusions, Intravenous
2
2016
420
0.120
 Why?
Africa
1
2017
113
0.120
 Why?
Foscarnet
3
2003
20
0.120
 Why?
Depression
3
2013
1501
0.120
 Why?
Triatoma
2
2006
7
0.120
 Why?
Nelfinavir
1
2016
8
0.120
 Why?
Latex Fixation Tests
1
1996
4
0.120
 Why?
Comorbidity
3
2019
1632
0.120
 Why?
Erythema
1
2016
28
0.120
 Why?
Lopinavir
1
2016
28
0.120
 Why?
Ribavirin
2
1994
71
0.120
 Why?
Atazanavir Sulfate
1
2016
42
0.120
 Why?
Insect Vectors
2
2006
39
0.120
 Why?
Frailty
1
2019
185
0.120
 Why?
Peptide Fragments
3
2007
700
0.120
 Why?
Autophagy
1
2018
285
0.120
 Why?
HIV Protease Inhibitors
1
2016
68
0.120
 Why?
Ritonavir
1
2016
71
0.120
 Why?
Bone Marrow Transplantation
3
1990
292
0.110
 Why?
Dipeptides
1
2015
56
0.110
 Why?
Lymphocyte Subsets
1
2015
87
0.110
 Why?
Genotype
3
2008
1828
0.110
 Why?
Hospitalization
2
2023
2329
0.110
 Why?
Drug Administration Schedule
3
2026
766
0.110
 Why?
Host-Pathogen Interactions
1
2018
370
0.110
 Why?
BK Virus
1
2015
17
0.110
 Why?
Brain Stem
1
1995
95
0.110
 Why?
Chronic Disease
6
2019
1818
0.110
 Why?
Programmed Cell Death 1 Receptor
1
2017
262
0.110
 Why?
Hematopoietic Stem Cell Transplantation
2
2015
677
0.110
 Why?
Data Interpretation, Statistical
3
2019
369
0.110
 Why?
Guatemala
1
2016
345
0.110
 Why?
Propylene Glycols
1
2015
27
0.110
 Why?
TOR Serine-Threonine Kinases
1
2018
446
0.110
 Why?
Medication Reconciliation
1
2015
30
0.110
 Why?
Global Health
1
2018
388
0.110
 Why?
Sphingosine
1
2015
45
0.110
 Why?
Reproducibility of Results
5
2013
3362
0.110
 Why?
Infant, Newborn, Diseases
1
2016
112
0.110
 Why?
Survival Rate
3
2016
2003
0.110
 Why?
Transfusion Reaction
1
1995
62
0.110
 Why?
COS Cells
2
2007
177
0.110
 Why?
Maus Elberfeld virus
2
1991
5
0.110
 Why?
Respiratory Syncytial Viruses
4
1993
58
0.110
 Why?
Maternal-Fetal Exchange
3
1995
169
0.110
 Why?
Species Specificity
3
2006
571
0.110
 Why?
Immunity, Mucosal
2
2012
99
0.110
 Why?
Chlamydia trachomatis
2
1991
51
0.110
 Why?
Histocompatibility Antigens Class I
1
1996
207
0.110
 Why?
Hemagglutinins, Viral
1
1994
6
0.110
 Why?
Clinical Trials, Phase III as Topic
3
2021
115
0.100
 Why?
Laryngeal Diseases
1
1994
31
0.100
 Why?
DNA-Directed DNA Polymerase
2
1992
48
0.100
 Why?
Rats
4
2006
5573
0.100
 Why?
Lymphoma
1
2015
229
0.100
 Why?
Autoantigens
1
1996
426
0.100
 Why?
Immunoglobulins, Intravenous
5
1995
128
0.100
 Why?
Zidovudine
2
2015
77
0.100
 Why?
Lamivudine
2
2015
63
0.100
 Why?
Needs Assessment
1
2016
389
0.100
 Why?
Analgesics
3
2010
226
0.100
 Why?
Controlled Clinical Trials as Topic
1
2013
28
0.100
 Why?
Cross-Over Studies
2
2013
591
0.100
 Why?
Placenta
2
1991
777
0.100
 Why?
Ethics, Research
1
2013
30
0.100
 Why?
Practice Guidelines as Topic
2
2017
1521
0.100
 Why?
Anti-Inflammatory Agents
3
2013
477
0.100
 Why?
Research Subjects
1
2013
43
0.100
 Why?
Mice, Inbred BALB C
3
2006
1262
0.100
 Why?
RNA Probes
2
1991
13
0.100
 Why?
Health Status
2
2010
819
0.100
 Why?
Epitopes, T-Lymphocyte
1
2014
184
0.100
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
1996
292
0.100
 Why?
Dose-Response Relationship, Drug
4
2026
2008
0.090
 Why?
Risk Assessment
4
2016
3533
0.090
 Why?
Measles Vaccine
1
2012
18
0.090
 Why?
Picornaviridae Infections
2
1990
50
0.090
 Why?
Autoimmune Diseases
1
1996
462
0.090
 Why?
Gene Expression Regulation, Viral
1
2012
99
0.090
 Why?
Human papillomavirus 31
1
2011
1
0.090
 Why?
Drug Resistance, Microbial
4
2001
67
0.090
 Why?
Immunosuppressive Agents
3
2015
842
0.090
 Why?
Ureaplasma urealyticum
1
1991
3
0.090
 Why?
Colorado
4
2018
4569
0.090
 Why?
Meningitis, Aseptic
1
1991
13
0.090
 Why?
Flow Cytometry
5
2017
1185
0.090
 Why?
Indoles
1
2015
474
0.090
 Why?
T-Lymphocytes, Cytotoxic
2
2011
176
0.090
 Why?
Efficiency
1
2012
102
0.090
 Why?
Linear Models
2
2010
853
0.090
 Why?
Chorioamnionitis
1
1991
45
0.090
 Why?
Insurance, Health
1
2014
294
0.080
 Why?
Mutation
5
2009
4024
0.080
 Why?
Cytotoxicity Tests, Immunologic
2
1996
37
0.080
 Why?
Gastroenteritis
2
1989
62
0.080
 Why?
Macrophages
3
2005
1503
0.080
 Why?
Neurogenesis
1
2012
157
0.080
 Why?
Neural Stem Cells
1
2012
166
0.080
 Why?
Sequence Alignment
2
2008
359
0.080
 Why?
Drug Design
1
2012
174
0.080
 Why?
Adjuvants, Pharmaceutic
2
2022
12
0.080
 Why?
Epidemiological Monitoring
3
2018
70
0.080
 Why?
Cervix Uteri
1
2010
52
0.080
 Why?
Exanthema
1
2011
82
0.080
 Why?
Serum
1
2010
58
0.080
 Why?
Sensitivity and Specificity
3
2009
1976
0.080
 Why?
Adenoviridae
9
2005
203
0.080
 Why?
Herpesviridae
2
1981
22
0.080
 Why?
Electrocardiography
2
2005
632
0.080
 Why?
Antidepressive Agents, Tricyclic
1
2010
31
0.080
 Why?
Herpesvirus Vaccines
1
2010
4
0.080
 Why?
Heart Rate
2
2006
838
0.080
 Why?
Antigen-Presenting Cells
5
2010
162
0.080
 Why?
Immunoglobulin M
1
1991
287
0.080
 Why?
Enterovirus B, Human
2
1988
25
0.080
 Why?
Health Services Accessibility
1
2018
1066
0.080
 Why?
Respiratory Tract Infections
1
1994
393
0.080
 Why?
Dermatomyositis
1
1989
24
0.080
 Why?
Medicaid
1
2014
453
0.080
 Why?
Poliovirus
2
2001
73
0.080
 Why?
DNA, Kinetoplast
2
2006
2
0.080
 Why?
Receptors, Virus
2
2006
96
0.070
 Why?
Placenta Diseases
1
1989
19
0.070
 Why?
Pilot Projects
1
2015
1830
0.070
 Why?
Protozoan Infections
1
1989
10
0.070
 Why?
Surveys and Questionnaires
7
2021
5954
0.070
 Why?
DNA Primers
2
2009
513
0.070
 Why?
Drug Stability
1
2009
165
0.070
 Why?
Thymidine Kinase
4
2001
16
0.070
 Why?
Skin Diseases, Viral
1
2008
6
0.070
 Why?
Oligonucleotide Probes
1
1988
50
0.070
 Why?
Geriatrics
1
2010
94
0.070
 Why?
Immunologic Deficiency Syndromes
2
1986
68
0.070
 Why?
Gene Expression
2
2006
1502
0.070
 Why?
Vagina
1
2010
200
0.070
 Why?
Muscles
1
1989
332
0.070
 Why?
Hydrocortisone
1
2010
304
0.070
 Why?
Postoperative Complications
2
2000
2869
0.070
 Why?
Geriatric Assessment
1
2010
226
0.070
 Why?
Kinetics
2
2010
1615
0.070
 Why?
In Vitro Techniques
6
2003
1051
0.070
 Why?
Administration, Intranasal
1
2008
93
0.070
 Why?
Interferon Type I
1
1989
143
0.070
 Why?
Poisson Distribution
2
2005
75
0.070
 Why?
Picornaviridae
1
1988
18
0.070
 Why?
Lipid A
2
2018
27
0.070
 Why?
Enterocolitis, Pseudomembranous
1
1988
28
0.070
 Why?
Anticonvulsants
1
2010
228
0.070
 Why?
Pertussis Vaccine
1
2007
24
0.070
 Why?
Evidence-Based Practice
1
2010
233
0.070
 Why?
Immunosorbent Techniques
1
2007
18
0.070
 Why?
Quality-Adjusted Life Years
1
2007
113
0.070
 Why?
Data Collection
1
2010
632
0.070
 Why?
Spinal Cord
2
2001
381
0.060
 Why?
Cricetulus
1
2007
110
0.060
 Why?
Prevalence
4
2018
2805
0.060
 Why?
Receptor, IGF Type 2
1
2006
5
0.060
 Why?
Acute Kidney Injury
1
2015
843
0.060
 Why?
Inhibitory Concentration 50
1
2006
91
0.060
 Why?
Vero Cells
1
2006
86
0.060
 Why?
Trypanosomatina
1
2006
1
0.060
 Why?
Opportunistic Infections
3
1993
44
0.060
 Why?
Public Health
1
2012
560
0.060
 Why?
Pregnancy Outcome
1
2010
463
0.060
 Why?
Research
1
2010
426
0.060
 Why?
Immunoglobulin Fragments
1
2006
11
0.060
 Why?
Animal Diseases
1
2006
8
0.060
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
1996
1833
0.060
 Why?
Neutralization Tests
5
2012
80
0.060
 Why?
Veterans
1
2018
1578
0.060
 Why?
NIH 3T3 Cells
1
2006
150
0.060
 Why?
Administration, Topical
4
2013
152
0.060
 Why?
Cyclic AMP
1
2007
208
0.060
 Why?
Random Allocation
6
1992
363
0.060
 Why?
Immunoglobulin Variable Region
1
2006
80
0.060
 Why?
Meningococcal Vaccines
1
2006
58
0.060
 Why?
Kaplan-Meier Estimate
3
2016
917
0.060
 Why?
Trees
1
2006
68
0.060
 Why?
Hepatitis A Vaccines
1
2026
20
0.060
 Why?
Nasopharyngeal Diseases
1
1985
5
0.060
 Why?
Logistic Models
2
2010
2088
0.060
 Why?
Hybridization, Genetic
9
1974
74
0.060
 Why?
Pneumonia, Viral
2
1990
381
0.060
 Why?
Motor Activity
1
2010
717
0.060
 Why?
Bone Marrow
2
1984
300
0.060
 Why?
Endocytosis
1
2006
170
0.060
 Why?
Sequence Analysis, DNA
3
2007
819
0.060
 Why?
GB virus C
1
2005
1
0.060
 Why?
Flaviviridae Infections
1
2005
2
0.060
 Why?
Uterine Cervical Dysplasia
2
2016
30
0.060
 Why?
Proportional Hazards Models
1
2009
1286
0.060
 Why?
Hepatitis, Viral, Human
1
2005
20
0.060
 Why?
Antineoplastic Agents
2
2016
2172
0.060
 Why?
Predictive Value of Tests
3
2010
2083
0.060
 Why?
HLA Antigens
3
1987
227
0.060
 Why?
Hydrogen-Ion Concentration
1
2006
557
0.060
 Why?
Normal Distribution
1
2005
21
0.060
 Why?
Evaluation Studies as Topic
3
1996
168
0.060
 Why?
Cell Differentiation
1
2012
2029
0.050
 Why?
Conservation of Natural Resources
1
2006
127
0.050
 Why?
Organ Transplantation
1
2008
247
0.050
 Why?
Blotting, Western
3
2015
1206
0.050
 Why?
Transfection
1
2007
941
0.050
 Why?
Autopsy
2
2001
93
0.050
 Why?
Open Reading Frames
2
2007
133
0.050
 Why?
Mammals
1
2006
288
0.050
 Why?
Neurons, Afferent
1
2005
102
0.050
 Why?
Risk
3
2016
897
0.050
 Why?
Disease Outbreaks
1
1988
423
0.050
 Why?
Receptors, Cholinergic
1
2004
40
0.050
 Why?
Macaca radiata
2
2001
15
0.050
 Why?
Cell Culture Techniques
1
2006
374
0.050
 Why?
Cell Adhesion Molecules
1
2005
177
0.050
 Why?
Receptors, Adrenergic, beta
1
2004
61
0.050
 Why?
Polymorphism, Restriction Fragment Length
1
2003
64
0.050
 Why?
Mental Health
1
2010
768
0.050
 Why?
Sex Factors
2
2003
2066
0.050
 Why?
Demography
2
2018
287
0.050
 Why?
Abdominal Neoplasms
1
2003
47
0.050
 Why?
Receptors, Cell Surface
1
2005
377
0.050
 Why?
Down-Regulation
1
2025
636
0.050
 Why?
2-Aminopurine
2
2007
8
0.050
 Why?
RNA
2
1988
934
0.050
 Why?
Polymorphism, Single Nucleotide
2
2009
2150
0.050
 Why?
Pre-Exposure Prophylaxis
1
2026
241
0.050
 Why?
Multicenter Studies as Topic
2
2001
388
0.050
 Why?
Membrane Glycoproteins
1
2005
495
0.050
 Why?
Adaptive Immunity
2
2017
169
0.050
 Why?
Biopsy
2
2000
1064
0.050
 Why?
Argentina
3
2006
29
0.050
 Why?
Poliomyelitis
2
2001
35
0.050
 Why?
Dendritic Cells
1
2025
494
0.050
 Why?
Neuroblastoma
1
2003
168
0.050
 Why?
Forecasting
3
2010
383
0.050
 Why?
Maltose-Binding Proteins
1
2001
13
0.050
 Why?
Hepatitis C
1
2004
249
0.040
 Why?
Glutathione Transferase
1
2001
99
0.040
 Why?
Cell Nucleus
3
1991
612
0.040
 Why?
Respirovirus Infections
2
1991
13
0.040
 Why?
Spondylarthropathies
1
2021
5
0.040
 Why?
Poliovirus Vaccine, Oral
1
2001
25
0.040
 Why?
Interspersed Repetitive Sequences
1
2000
5
0.040
 Why?
Peripheral Nerves
1
2001
72
0.040
 Why?
Blotting, Southern
1
2000
83
0.040
 Why?
Expressed Sequence Tags
1
2000
43
0.040
 Why?
Mutagenesis
1
2001
186
0.040
 Why?
Fatal Outcome
1
2001
305
0.040
 Why?
Endocardium
1
2000
31
0.040
 Why?
Secondary Prevention
2
2013
236
0.040
 Why?
Alanine
1
2001
168
0.040
 Why?
Cloning, Molecular
1
2001
535
0.040
 Why?
Blotting, Northern
1
2000
200
0.040
 Why?
Phosphorylation
2
2002
1746
0.040
 Why?
Genome, Viral
1
2002
222
0.040
 Why?
Virion
1
2001
114
0.040
 Why?
Sex Characteristics
2
2017
782
0.040
 Why?
DNA, Protozoan
1
2000
32
0.040
 Why?
Consensus Sequence
1
2000
75
0.040
 Why?
Amino Acid Motifs
1
2000
223
0.040
 Why?
DEAD-box RNA Helicases
1
2000
90
0.040
 Why?
Canada
2
2012
422
0.040
 Why?
Psoriasis
1
2021
110
0.040
 Why?
Amniotic Fluid
3
1991
79
0.040
 Why?
Chromosome Mapping
1
2000
506
0.040
 Why?
Immunity, Innate
1
2025
848
0.040
 Why?
Autoimmunity
1
2005
922
0.040
 Why?
Transcription, Genetic
5
2000
1495
0.040
 Why?
Sequence Homology, Amino Acid
1
2000
390
0.040
 Why?
Enterotoxins
2
1994
89
0.040
 Why?
Sleep
1
2006
903
0.040
 Why?
Recombinant Fusion Proteins
1
2001
673
0.040
 Why?
Rats, Sprague-Dawley
1
2004
2509
0.040
 Why?
Saponins
1
2018
10
0.040
 Why?
Hematopoietic Stem Cells
1
1982
416
0.030
 Why?
Seroconversion
1
2018
50
0.030
 Why?
Saliva
2
2010
247
0.030
 Why?
Haptoglobins
1
2018
64
0.030
 Why?
Encephalitis, Viral
1
1998
45
0.030
 Why?
Drug Compounding
1
2018
102
0.030
 Why?
Protein Precursors
1
2018
134
0.030
 Why?
Immunologic Techniques
2
1994
39
0.030
 Why?
Glucosides
1
2017
52
0.030
 Why?
Celiac Disease
1
2021
306
0.030
 Why?
Inositol Phosphates
1
2017
21
0.030
 Why?
Sterols
1
2017
20
0.030
 Why?
Botswana
1
2017
9
0.030
 Why?
Health Surveys
1
2019
506
0.030
 Why?
Cell Transformation, Neoplastic
5
1977
339
0.030
 Why?
International Cooperation
1
2018
197
0.030
 Why?
Internationality
1
2018
154
0.030
 Why?
Graft Rejection
1
2000
535
0.030
 Why?
Chemotaxis
1
2017
122
0.030
 Why?
Zimbabwe
1
2017
67
0.030
 Why?
Zambia
1
2017
56
0.030
 Why?
Tanzania
1
2017
60
0.030
 Why?
Bisoprolol
1
1996
2
0.030
 Why?
Antigens, Bacterial
1
2017
125
0.030
 Why?
Plasma
1
2018
226
0.030
 Why?
Patient Safety
1
2020
336
0.030
 Why?
Recovery of Function
1
2021
691
0.030
 Why?
Propanolamines
1
1996
39
0.030
 Why?
Cerebrospinal Fluid
2
1993
91
0.030
 Why?
Acute Disease
2
2011
994
0.030
 Why?
Immune Tolerance
4
1998
376
0.030
 Why?
Biomarkers
2
2018
4227
0.030
 Why?
Leukemia, Lymphoid
2
1986
27
0.030
 Why?
Sinusitis
1
1999
237
0.030
 Why?
False Negative Reactions
1
1996
63
0.030
 Why?
Public Health Surveillance
1
2016
83
0.030
 Why?
False Positive Reactions
1
1996
125
0.030
 Why?
Amniocentesis
2
1991
20
0.030
 Why?
Inhibitor of Apoptosis Proteins
1
2015
47
0.030
 Why?
AIDS Dementia Complex
1
2015
52
0.030
 Why?
Analysis of Variance
2
2011
1301
0.030
 Why?
Depressive Disorder
1
1998
365
0.030
 Why?
Nevirapine
1
2015
18
0.030
 Why?
Half-Life
2
1992
148
0.030
 Why?
Cross-Sectional Studies
4
2011
5726
0.030
 Why?
Adrenergic beta-Antagonists
1
1996
223
0.030
 Why?
Chi-Square Distribution
2
2013
513
0.030
 Why?
Nausea
1
2015
111
0.030
 Why?
Vomiting
1
2015
130
0.030
 Why?
Area Under Curve
1
2015
331
0.030
 Why?
Bromodeoxyuridine
2
2007
79
0.030
 Why?
Fingolimod Hydrochloride
1
2015
39
0.030
 Why?
Disease Susceptibility
1
1996
348
0.030
 Why?
Gene Regulatory Networks
1
2017
320
0.030
 Why?
Product Surveillance, Postmarketing
1
2015
68
0.030
 Why?
Breast Feeding
1
2018
442
0.030
 Why?
Neutropenia
1
2015
150
0.030
 Why?
Belgium
1
2014
12
0.030
 Why?
Vaccines, Virus-Like Particle
1
2014
3
0.030
 Why?
Headache
1
2015
152
0.030
 Why?
HLA-A2 Antigen
1
2014
47
0.030
 Why?
Metabolic Diseases
1
2015
114
0.030
 Why?
Rubella
1
1974
22
0.030
 Why?
Bacterial Proteins
1
2000
923
0.030
 Why?
Culture Media
2
1984
159
0.030
 Why?
Immunoblotting
1
1994
307
0.030
 Why?
Tetanus Toxoid
1
1994
34
0.030
 Why?
Probability
2
2005
300
0.030
 Why?
Hemagglutinin Glycoproteins, Influenza Virus
1
1994
24
0.030
 Why?
Drugs, Investigational
1
2014
31
0.030
 Why?
Anemia
1
2015
178
0.030
 Why?
Statistics, Nonparametric
2
2004
428
0.030
 Why?
Seroepidemiologic Studies
1
2014
171
0.020
 Why?
Phenotype
1
2002
3160
0.020
 Why?
Thrombocytopenia
1
2015
206
0.020
 Why?
Developed Countries
1
2013
37
0.020
 Why?
Haplorhini
8
1974
52
0.020
 Why?
Mortality
1
2015
360
0.020
 Why?
Drug Tolerance
1
1992
100
0.020
 Why?
Human papillomavirus 6
1
2011
3
0.020
 Why?
Ureaplasma Infections
1
1991
3
0.020
 Why?
Mycoplasma Infections
1
1991
16
0.020
 Why?
Arthritis, Rheumatoid
1
2021
1168
0.020
 Why?
Genetics, Microbial
3
1971
10
0.020
 Why?
Skin
2
1989
755
0.020
 Why?
Safety
1
1994
352
0.020
 Why?
Genitalia, Female
1
2012
41
0.020
 Why?
gamma-Globulins
1
1991
13
0.020
 Why?
Antibodies, Heterophile
1
1991
13
0.020
 Why?
Epstein-Barr Virus Nuclear Antigens
1
1991
12
0.020
 Why?
Phylogeny
2
2006
1009
0.020
 Why?
Absenteeism
1
2012
52
0.020
 Why?
Adrenal Cortex Hormones
1
2015
498
0.020
 Why?
Metabolomics
1
2017
718
0.020
 Why?
Adenoviruses, Human
1
1991
27
0.020
 Why?
Hospitals, University
1
1991
173
0.020
 Why?
Matched-Pair Analysis
1
2011
37
0.020
 Why?
Early Detection of Cancer
1
2016
447
0.020
 Why?
Bodily Secretions
1
2010
2
0.020
 Why?
Paramyxoviridae Infections
1
1990
12
0.020
 Why?
North America
1
2012
309
0.020
 Why?
Tritium
7
1974
68
0.020
 Why?
Diagnosis, Differential
3
2009
1496
0.020
 Why?
Europe
1
2012
407
0.020
 Why?
Inflammation
2
2017
2883
0.020
 Why?
DNA
4
1988
1412
0.020
 Why?
Schwann Cells
1
1990
33
0.020
 Why?
Chlamydia Infections
1
1991
82
0.020
 Why?
Bacterial Infections
2
2001
247
0.020
 Why?
Antigens
2
1970
349
0.020
 Why?
Rhinovirus
1
1990
57
0.020
 Why?
Antigens, Surface
2
1987
156
0.020
 Why?
Serotyping
2
1988
32
0.020
 Why?
Cell Proliferation
1
2018
2516
0.020
 Why?
Health Planning Guidelines
1
2010
23
0.020
 Why?
Self Administration
1
2010
125
0.020
 Why?
Gene Expression Profiling
1
2017
1791
0.020
 Why?
Drug Resistance, Neoplasm
1
2015
866
0.020
 Why?
Gestational Age
2
1989
970
0.020
 Why?
Hepatitis B Antibodies
1
2009
8
0.020
 Why?
beta-Globins
1
2009
8
0.020
 Why?
In Situ Hybridization
2
2001
320
0.020
 Why?
Contraceptive Devices, Male
1
1989
1
0.020
 Why?
Subacute Sclerosing Panencephalitis
1
1989
6
0.020
 Why?
Spermatocidal Agents
1
1989
7
0.020
 Why?
Ribonucleosides
1
1989
7
0.020
 Why?
Immunohistochemistry
1
1993
1722
0.020
 Why?
Reference Values
1
2011
805
0.020
 Why?
Physical Examination
1
2010
234
0.020
 Why?
Prenatal Exposure Delayed Effects
1
2016
666
0.020
 Why?
Thymidine
4
1980
59
0.020
 Why?
RNA, Antisense
1
1988
18
0.020
 Why?
Reference Standards
1
2009
181
0.020
 Why?
Nasal Mucosa
1
2009
111
0.020
 Why?
Astrocytes
1
1990
218
0.020
 Why?
Virus Cultivation
4
1984
31
0.020
 Why?
Reoviridae
1
1988
36
0.020
 Why?
Mammalian orthoreovirus 3
1
1988
37
0.020
 Why?
Measles
1
1989
44
0.020
 Why?
Hepatitis
1
1988
43
0.020
 Why?
DNA, Recombinant
1
1988
48
0.020
 Why?
Disease Progression
1
2016
2851
0.020
 Why?
Reoviridae Infections
1
1988
54
0.020
 Why?
Cancer Vaccines
1
2009
167
0.020
 Why?
Neoplasms, Experimental
1
1969
172
0.020
 Why?
Sequence Homology, Nucleic Acid
1
1988
156
0.020
 Why?
Fetus
1
1992
799
0.020
 Why?
Health Services Needs and Demand
1
2010
277
0.020
 Why?
Cytopathogenic Effect, Viral
2
1982
16
0.020
 Why?
Microscopy, Electron
3
2001
414
0.020
 Why?
Body Fluids
1
1987
71
0.020
 Why?
Australia
1
2008
283
0.020
 Why?
Biliary Atresia
1
1988
144
0.020
 Why?
Noma
1
1986
2
0.020
 Why?
Heptavalent Pneumococcal Conjugate Vaccine
1
2006
13
0.020
 Why?
Xenodiagnosis
1
2006
2
0.020
 Why?
Apoptosis
1
2015
2431
0.020
 Why?
Telomere
1
2010
283
0.020
 Why?
Gastrointestinal Hemorrhage
1
1988
126
0.020
 Why?
Valine
1
2007
79
0.020
 Why?
Embryo, Mammalian
3
1973
234
0.010
 Why?
Interleukin-4
2
1998
212
0.010
 Why?
Amino Acid Substitution
1
2007
300
0.010
 Why?
Kidney
9
1975
1480
0.010
 Why?
RNA, Ribosomal
1
2006
165
0.010
 Why?
Statistics as Topic
1
2006
279
0.010
 Why?
Reagent Kits, Diagnostic
1
1985
35
0.010
 Why?
Anti-Bacterial Agents
2
1999
1892
0.010
 Why?
Ketones
1
1986
52
0.010
 Why?
Gene Amplification
1
2006
111
0.010
 Why?
Nectins
1
2005
7
0.010
 Why?
Lymphoproliferative Disorders
1
1985
54
0.010
 Why?
Mass Screening
1
2014
1318
0.010
 Why?
Residence Characteristics
1
2008
376
0.010
 Why?
Factor Analysis, Statistical
1
2006
289
0.010
 Why?
Carbon Isotopes
5
1973
142
0.010
 Why?
California
1
2006
464
0.010
 Why?
Toll-Like Receptor 2
1
2005
120
0.010
 Why?
Streptococcus pneumoniae
1
2006
176
0.010
 Why?
Chromosomes, Human
1
1984
44
0.010
 Why?
Cytotoxicity, Immunologic
1
1985
223
0.010
 Why?
Hexuronic Acids
1
1984
23
0.010
 Why?
Toll-Like Receptors
1
2005
189
0.010
 Why?
Glucuronic Acid
1
1984
25
0.010
 Why?
Intensive Care Units, Neonatal
1
1988
271
0.010
 Why?
Alginates
1
1984
49
0.010
 Why?
Freezing
1
1984
86
0.010
 Why?
Filtration
1
1984
69
0.010
 Why?
Polyethylene Glycols
1
1989
634
0.010
 Why?
Culture Techniques
4
1973
67
0.010
 Why?
Bone Marrow Cells
1
1984
317
0.010
 Why?
RNA, Small Interfering
1
2005
638
0.010
 Why?
Fetal Blood
1
1985
333
0.010
 Why?
Stomatitis, Herpetic
1
1982
5
0.010
 Why?
Phosphonoacetic Acid
1
1982
10
0.010
 Why?
Socioeconomic Factors
1
2007
1320
0.010
 Why?
Up-Regulation
1
2005
859
0.010
 Why?
Agammaglobulinemia
1
1982
35
0.010
 Why?
Isoelectric Focusing
1
2001
30
0.010
 Why?
Prognosis
1
2010
4159
0.010
 Why?
NF-kappa B
1
2005
666
0.010
 Why?
Rural Population
1
2006
613
0.010
 Why?
Ulnar Nerve
1
2001
17
0.010
 Why?
Interleukin-6
1
2005
784
0.010
 Why?
Brain
1
1993
2886
0.010
 Why?
Temperature
1
1984
679
0.010
 Why?
Electrophoresis, Polyacrylamide Gel
1
2001
329
0.010
 Why?
Cell Survival
1
1984
1104
0.010
 Why?
Administration, Oral
2
1997
834
0.010
 Why?
Phytohemagglutinins
1
1980
29
0.010
 Why?
Serum Albumin
1
2001
150
0.010
 Why?
Disease Models, Animal
1
1991
4528
0.010
 Why?
Neuroglia
1
2001
173
0.010
 Why?
Phagocytosis
1
1982
295
0.010
 Why?
Ribosomes
1
2001
190
0.010
 Why?
Cell Communication
1
1982
322
0.010
 Why?
Ambulatory Care
1
2004
588
0.010
 Why?
Leukocytes
1
1981
293
0.010
 Why?
Air Microbiology
1
1980
48
0.010
 Why?
Nasal Decongestants
1
1999
8
0.010
 Why?
Immunity, Maternally-Acquired
1
1979
18
0.010
 Why?
Otorhinolaryngologic Surgical Procedures
1
1999
39
0.010
 Why?
Immunoglobulins
1
1979
162
0.010
 Why?
Mitogens
1
1978
56
0.010
 Why?
Lectins
1
1978
43
0.010
 Why?
Steroids
1
1999
161
0.010
 Why?
Rabbits
1
1979
656
0.010
 Why?
Th2 Cells
1
1998
181
0.010
 Why?
Amanitins
1
1977
4
0.010
 Why?
Bronchopulmonary Dysplasia
2
1993
407
0.010
 Why?
Cross Infection
1
1980
259
0.010
 Why?
Centrifugation, Density Gradient
3
1971
39
0.010
 Why?
Antigen-Antibody Complex
1
1997
72
0.010
 Why?
Interleukin-10
1
1998
310
0.010
 Why?
Combined Modality Therapy
1
1999
1242
0.010
 Why?
Erythrocytes
1
1982
746
0.010
 Why?
Adenoviridae Infections
1
1975
20
0.010
 Why?
Evidence-Based Medicine
1
1999
705
0.010
 Why?
Indicator Dilution Techniques
1
1994
12
0.010
 Why?
Patient Selection
1
1999
688
0.010
 Why?
Uridine
2
1973
30
0.010
 Why?
Centrifugation, Zonal
2
1971
2
0.010
 Why?
Abortion, Therapeutic
1
1974
3
0.010
 Why?
Rubella virus
1
1974
7
0.010
 Why?
Heart Defects, Congenital
2
1993
873
0.010
 Why?
Cesium
2
1971
20
0.010
 Why?
Molecular Biology
2
1971
60
0.010
 Why?
Sucrose
2
1971
112
0.010
 Why?
Chlorides
2
1971
136
0.010
 Why?
Complement Fixation Tests
2
1984
5
0.010
 Why?
Pulmonary Fibrosis
1
1975
394
0.010
 Why?
Hemagglutination Tests
1
1991
7
0.010
 Why?
Genes
1
1971
225
0.010
 Why?
Stress, Psychological
1
1998
1137
0.000
 Why?
Population Surveillance
1
1993
490
0.000
 Why?
Nonoxynol
1
1989
4
0.000
 Why?
Latex
1
1989
8
0.000
 Why?
Kidney Transplantation
1
1975
692
0.000
 Why?
Suspensions
1
1987
29
0.000
 Why?
Ribonucleases
1
1987
49
0.000
 Why?
Chloroquine
1
1987
54
0.000
 Why?
Deltaretrovirus
1
1986
12
0.000
 Why?
Binding, Competitive
1
1985
192
0.000
 Why?
Leukocyte Count
1
1985
317
0.000
 Why?
Mitosis
1
1985
200
0.000
 Why?
Histocompatibility Antigens Class II
1
1985
366
0.000
 Why?
Serologic Tests
1
1983
52
0.000
 Why?
Histocompatibility Antigens
2
1974
103
0.000
 Why?
Infusions, Parenteral
1
1982
42
0.000
 Why?
Leukemia
1
1983
246
0.000
 Why?
Hospital Bed Capacity, 300 to 499
1
1980
3
0.000
 Why?
Air Movements
1
1980
10
0.000
 Why?
Hospital Units
1
1980
32
0.000
 Why?
Boston
1
1980
93
0.000
 Why?
Liver
1
1988
1840
0.000
 Why?
Communicable Disease Control
1
1980
86
0.000
 Why?
Methods
1
1978
67
0.000
 Why?
p-Fluorophenylalanine
1
1976
2
0.000
 Why?
Cycloheximide
1
1976
47
0.000
 Why?
Hospitals, Pediatric
1
1980
545
0.000
 Why?
Inclusion Bodies, Viral
1
1975
3
0.000
 Why?
Cytoplasm
1
1976
267
0.000
 Why?
Cadaver
1
1975
301
0.000
 Why?
Transplantation, Homologous
1
1975
411
0.000
 Why?
Genetic Code
1
1971
22
0.000
 Why?
Nucleic Acid Denaturation
1
1971
31
0.000
 Why?
Chymotrypsin
1
1971
23
0.000
 Why?
Platinum
1
1971
50
0.000
 Why?
Molecular Weight
1
1971
323
0.000
 Why?
Carbon
1
1971
203
0.000
 Why?
DNA Replication
1
1971
253
0.000
 Why?
Hot Temperature
1
1971
406
0.000
 Why?
Lung
1
1975
4131
0.000
 Why?
Levin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (855) concept(s)
_
Co-Authors Expand Description
See all (23) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)